Blackcomb Advisors is a global firm providing novel fund structuring, due diligence, M&A, licensing, strategic advisory and CEO services across the following areas:

  • hedge funds, private equity, venture capital, family and public investment funds, investment banking, corporate strategics  
  • focus on health care; specifically, biotech, pharma, medical devices, drug delivery, diagnostics, information technology
  • expertise across all major therapeutic areas, including oncology, infectious disease, general medicine, women's health, vaccines, gene therapy, biologics
  • functional expertise across fund structuring, general management, global and domestic marketing, licensing, M&A, finance, venture investing (private, corporate and LP perspectives) and senior advisory